- Home
- HOTH vs ISPC Comparison
HOTH vs ISPC Comparison
Compare HOTH & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- ISPC
- Stock Information
- Founded
- HOTH 2017
- ISPC 2009
- Country
- HOTH United States
- ISPC United States
- Employees
- HOTH N/A
- ISPC N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- HOTH Health Care
- ISPC Health Care
- Exchange
- HOTH Nasdaq
- ISPC Nasdaq
- Market Cap
- HOTH 4.9M
- ISPC 4.7M
- IPO Year
- HOTH 2019
- ISPC 2021
- Fundamental
- Price
- HOTH $1.50
- ISPC $2.37
- Analyst Decision
- HOTH Strong Buy
- ISPC
- Analyst Count
- HOTH 4
- ISPC 0
- Target Price
- HOTH $4.75
- ISPC N/A
- AVG Volume (30 Days)
- HOTH 25.5M
- ISPC 1.2M
- Earning Date
- HOTH 11-12-2024
- ISPC 03-12-2025
- Dividend Yield
- HOTH N/A
- ISPC N/A
- EPS Growth
- HOTH N/A
- ISPC N/A
- EPS
- HOTH N/A
- ISPC N/A
- Revenue
- HOTH N/A
- ISPC $10,390,702.00
- Revenue This Year
- HOTH N/A
- ISPC $13.82
- Revenue Next Year
- HOTH N/A
- ISPC $11.76
- P/E Ratio
- HOTH N/A
- ISPC N/A
- Revenue Growth
- HOTH N/A
- ISPC 0.74
- 52 Week Low
- HOTH $0.58
- ISPC $2.30
- 52 Week High
- HOTH $3.80
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- HOTH 58.81
- ISPC 34.01
- Support Level
- HOTH $1.50
- ISPC $2.50
- Resistance Level
- HOTH $1.71
- ISPC $2.79
- Average True Range (ATR)
- HOTH 0.45
- ISPC 0.28
- MACD
- HOTH 0.04
- ISPC 0.02
- Stochastic Oscillator
- HOTH 25.54
- ISPC 6.48
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.